Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study

Documenti analoghi

• Proceedings of the 36th Annual Meeting and Scientific Symposium
  di: Ismene L. Petrakis
  Pubblicazione: (2026)
• Proceedings of the 35th Annual Meeting & Scientific Symposium
  di: Thomas R. Kosten, et al.
  Pubblicazione: (2025)
• Highlights and insights from the 34th AAAP Annual Meeting and Scientific Symposium
  di: Thomas R. Kosten, et al.
  Pubblicazione: (2024)
• How changes in post‐traumatic stress disorder (PTSD) severity mediate substance use disorder (SUD) severity during and after treatment for co‐occurring PTSD and SUD: Results from Project Harmony
  di: Denise A. Hien, et al.
  Pubblicazione: (2025)
• Somatic and psychiatric comorbidity in people with diagnosed gambling disorder: A Finnish nation‐wide register study
  di: Tanja Grönroos, et al.
  Pubblicazione: (2024)